Ob2F3-expressing Tregs from either healthy adults or MS patients could suppress MBP-specific T effector cells, but were also able to suppress T cells with other specificities after Tregs had been activated through the TCR (27). This evidence concerns the gene MBP and myeloid sarcoma.